TECH vs TRNS · P/E 65, rev $1.22B vs P/E 57, rev $278.4M
Bio-Techne Corp (TECH) versus Transcat Inc (TRNS) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Transcat Inc (TRNS) is a specialty business services company listed on US.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported TRNS revenue for 2025-03-29 was $278.4M. Net income was $14.5M. Revenue was up 7.3% from 2024-03-30 to 2025-03-29. TRNS currently screens at market cap $837.5M and trailing P/E 57.2.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. TRNS currently screens at market cap $837.5M and trailing P/E 57.2.
Not investment advice. Open the TECH and TRNS stock pages for the full models.
Not investment advice.